Will the President’s Advisory Council on HIV/AIDS ever be useful again? by Tim Murphy, TheBody - The HIV/Aids Resource | Mar 23, 2021
CMS nixes proposed Part D protected drug class changes made by Trump admin by Robert King, Fierce Healthcare | Mar 17, 2021
Biden CMS scraps Trump CMS plan to weaken Part D patient protections by John Wilkerson, Inside Health Policy | Mar 16, 2021
Patient groups warn HHS against weakening protected drug classes by John Wilkerson, Inside Health Policy | Feb 26, 2021
HIV group urges Biden HHS to undo Trump’s copay coupon policy by Gabrielle Wanneh, Inside Health Policy | Feb 2, 2021
